PerkinElmer to Expand Neonatal Screening Program in Israel
PerkinElmer, Inc. announced that its neonatal screening technology has been selected by State of Israel's Chaim Sheba Medical Center, Tel Aviv, to create a comprehensive newborn screening program that is intended to cover every child born in Israel. Under the terms of this agreement, PerkinElmer will provide the State of Israel with instrumentation, reagents, scientific expertise, and a robust informatics system that will enhance the nation's neonatal screening and data management capabilities.
The contract, to be executed through PerkinElmer's regional distributors HVD Vertriebs Gmbh and Gamidor Limited, will fulfill a recent mandate by the Medical Research Infrastructure Development and Health Services Fund to substantially expand its newborn screening program to cover Israel's entire population and increase the number of tests that will be screened for indications of disease. Approximately 120,000 babies are born each year in Israel, which has a population of about 6.3 million.
Other news from the department business & finance

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.